Latest biotech News

US FDA grants new fast designation for Bionomics’ BNC210
New discoveries make steps toward lipoedema diagnosis and treatment
Call for Australasian Biotechnology journal abstracts
CSL Joins StartX Community
New BARD1 exosome liquid biopsy agreement with Griffith University
Victoria produces Australia’s first mRNA Covid vaccine candidate
ResApp receives first regulatory approvals for cough counter smartphone application
AusBiotech welcomes Parliamentary Inquiry report
Biotron’s BIT225 effective against Covid in animal study
CSL’s new headquarters will be home to biotech incubator
Member feedback sought on mandatory reporting of adverse events
Melbourne Biotech Incubator
Call for AusMedtech 2022 session submissions
Telix Pharmaceuticals says first Australian patient doses in global study
AusBiotech highlights cell and gene therapy opportunity to Senate Inquiry
Nirtek begins R&D collaboration with TTRA funding support
AusBiotech calls for feedback on National One Stop Shop for clinical trials
Winner of 2021’s Prime Minister’s Prize for Innovation congratulated
Mr Geoffrey Kempler announced as new AusBiotech Chair
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
Decadal Biotech Blueprint opens for sector-wide consultation
TGA recognises two more Covid vaccines not registered in Australia but used widely internationally
Rhinomed announces details of new trial for Rhinoswab
$2.5 million CSL Centenary Fellowships awarded
Life sciences’ highest achievers awarded with prestigious Industry Excellence Awards
Final ‘foundation stones’ set for future of Australian regenerative medicine
Australia’s biggest week in biotech begins
Australia’s premier life sciences conferences celebrate and champion sector
Rockhampton Angel Investment Network takes out national prize
Australian businesses invited to advance future of healthcare technologies in Medtronic challenge
Hearing company Hemideina completes successful capital raise
Proposal to amend definitions of GM for food classifications
Late-stage trial for Dimerix’s investigative Covid treatment
Voluntary standardised IP framework supported
CSL Research and Development Day 2021
IDT announces deal with Monash to produce mRNA vaccine for trial
Bright ideas sought to keep our country disease and pest free
CSL Committed to AZ COVID Vaccine
CV-19 vaccine designer joins AusBiotech 2021 line-up
CSL Requires Covid Vaccination
NSW’s first trade statement aims to double exports by 2031
Global Pipeline Tracker provides view of global pipeline and possible cell and gene therapies for Australia
Standardised agreements proposed to support commercialisation
EnGeneIC launches trial of nano cellular Covid vaccine
Cynata Therapeutics announces publication of new paper
Indian regulator approves study of Dimerix’s DMX-200 in Covid
EOI sought for new Cell and Gene Catalyst
New research shows drug repurposing is no ‘quick-fix’ in race to treat Covid